Companhia Brasileira de Aluminio
BOVESPA:CBAV3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Companhia Brasileira de Aluminio
BOVESPA:CBAV3
|
BR |
|
Egetis Therapeutics AB (publ)
STO:EGTX
|
SE |
|
Adidas AG
XETRA:ADS
|
DE |
|
P
|
Providence Resources Inc
OTC:PVRS
|
US |
|
WPP PLC
LSE:WPP
|
UK |
Balance Sheet
Balance Sheet Decomposition
Companhia Brasileira de Aluminio
Companhia Brasileira de Aluminio
Balance Sheet
Companhia Brasileira de Aluminio
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
162
|
117
|
190
|
632
|
1 449
|
849
|
1 350
|
1 142
|
1 268
|
|
| Cash |
19
|
42
|
138
|
356
|
335
|
453
|
746
|
686
|
423
|
|
| Cash Equivalents |
143
|
75
|
52
|
276
|
1 115
|
396
|
604
|
456
|
845
|
|
| Short-Term Investments |
941
|
569
|
416
|
617
|
337
|
340
|
379
|
385
|
57
|
|
| Total Receivables |
823
|
847
|
1 051
|
917
|
993
|
929
|
743
|
752
|
858
|
|
| Accounts Receivables |
384
|
490
|
404
|
475
|
698
|
496
|
382
|
494
|
632
|
|
| Other Receivables |
439
|
357
|
646
|
442
|
295
|
432
|
361
|
259
|
226
|
|
| Inventory |
660
|
827
|
928
|
1 070
|
1 592
|
1 881
|
1 937
|
2 163
|
2 046
|
|
| Other Current Assets |
294
|
221
|
84
|
169
|
83
|
271
|
452
|
120
|
228
|
|
| Total Current Assets |
2 879
|
2 581
|
2 669
|
3 405
|
4 455
|
4 270
|
4 862
|
4 562
|
4 458
|
|
| PP&E Net |
4 831
|
4 800
|
4 737
|
5 122
|
5 195
|
5 530
|
5 977
|
6 425
|
6 650
|
|
| PP&E Gross |
4 831
|
4 800
|
4 737
|
5 122
|
5 195
|
5 530
|
5 977
|
6 425
|
6 650
|
|
| Accumulated Depreciation |
5 205
|
5 433
|
5 615
|
6 113
|
6 439
|
6 433
|
6 470
|
7 283
|
8 821
|
|
| Intangible Assets |
375
|
368
|
325
|
365
|
832
|
731
|
717
|
684
|
689
|
|
| Goodwill |
166
|
166
|
166
|
166
|
166
|
226
|
184
|
184
|
184
|
|
| Note Receivable |
1 789
|
657
|
765
|
865
|
743
|
752
|
726
|
701
|
660
|
|
| Long-Term Investments |
344
|
199
|
207
|
199
|
205
|
0
|
277
|
238
|
284
|
|
| Other Long-Term Assets |
960
|
932
|
945
|
1 089
|
369
|
766
|
819
|
1 040
|
1 041
|
|
| Other Assets |
166
|
166
|
166
|
166
|
166
|
226
|
184
|
184
|
184
|
|
| Total Assets |
11 343
N/A
|
9 704
-14%
|
9 816
+1%
|
11 211
+14%
|
11 965
+7%
|
12 275
+3%
|
13 562
+10%
|
13 833
+2%
|
13 966
+1%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
423
|
391
|
407
|
1 021
|
887
|
1 013
|
959
|
1 321
|
1 225
|
|
| Accrued Liabilities |
182
|
151
|
165
|
250
|
241
|
205
|
240
|
258
|
268
|
|
| Short-Term Debt |
38
|
257
|
335
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
229
|
118
|
136
|
73
|
97
|
124
|
124
|
160
|
187
|
|
| Other Current Liabilities |
788
|
416
|
191
|
648
|
936
|
847
|
733
|
607
|
750
|
|
| Total Current Liabilities |
1 660
|
1 332
|
1 234
|
1 991
|
2 160
|
2 189
|
2 056
|
2 346
|
2 429
|
|
| Long-Term Debt |
2 589
|
1 941
|
2 060
|
2 890
|
3 054
|
2 877
|
4 269
|
4 653
|
4 308
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
40
|
13
|
12
|
16
|
11
|
|
| Minority Interest |
113
|
182
|
186
|
177
|
215
|
228
|
246
|
227
|
223
|
|
| Other Liabilities |
1 434
|
1 184
|
1 394
|
2 590
|
1 996
|
1 873
|
2 520
|
2 806
|
2 703
|
|
| Total Liabilities |
5 796
N/A
|
4 639
-20%
|
4 874
+5%
|
7 648
+57%
|
7 464
-2%
|
7 179
-4%
|
9 103
+27%
|
10 049
+10%
|
9 674
-4%
|
|
| Equity | ||||||||||
| Common Stock |
5 637
|
4 950
|
4 950
|
4 950
|
4 705
|
4 705
|
4 890
|
4 911
|
4 510
|
|
| Retained Earnings |
5
|
37
|
58
|
986
|
183
|
674
|
234
|
471
|
22
|
|
| Unrealized Security Profit/Loss |
94
|
77
|
50
|
401
|
388
|
283
|
198
|
656
|
240
|
|
| Total Equity |
5 548
N/A
|
5 064
-9%
|
4 942
-2%
|
3 563
-28%
|
4 501
+26%
|
5 096
+13%
|
4 458
-13%
|
3 784
-15%
|
4 292
+13%
|
|
| Total Liabilities & Equity |
11 343
N/A
|
9 704
-14%
|
9 816
+1%
|
11 211
+14%
|
11 965
+7%
|
12 275
+3%
|
13 562
+10%
|
13 833
+2%
|
13 966
+1%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
596
|
596
|
596
|
597
|
597
|
597
|
645
|
651
|
651
|
|